{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:42:59Z","timestamp":1791474179939,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118348","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:51:08Z","timestamp":1755553868000},"page":"118348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Design and synthesis of new pyridazinone derivatives as selective COX-2 inhibitors: In-vitro and in-vivo evaluation of the anti-inflammatory activity, histopathological studies and molecular modelling"],"prefix":"10.1016","volume":"130","author":[{"given":"Rasha A.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4696-3170","authenticated-orcid":false,"given":"Eman M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7739-3037","authenticated-orcid":false,"given":"Sara Y.","family":"Ewieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr M.","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaymaa G.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh S.","family":"Zaghlool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa S.A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118348_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29390","article-title":"Design, synthesis, biological and computational screening of novel pyridine-based thiadiazole derivatives as prospective anti-inflammatory agents","volume":"10","author":"Podila","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bmc.2025.118348_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10787-022-00927-x","article-title":"Advancement of nanomedicines in chronic inflammatory disorders","volume":"30","author":"Jogpal","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bmc.2025.118348_bb0015","first-page":"83","article-title":"The challenge of managing atopic dermatitis in the United States","volume":"12","author":"Feldman","year":"2019","journal-title":"Am Heal Drug Benefits"},{"key":"10.1016\/j.bmc.2025.118348_bb0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/jmp5040030","article-title":"Rheumatoid arthritis: What inflammation do we face?","volume":"5","author":"Poznyak","year":"2024","journal-title":"J. Mol. Pathol."},{"key":"10.1016\/j.bmc.2025.118348_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X211022149","article-title":"Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe?","volume":"13","author":"Cadet","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.bmc.2025.118348_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.817","article-title":"Kidney damage from nonsteroidal anti-inflammatory drugs\u2014myth or truth? Review of selected literature","volume":"9","author":"Dro\u017cd\u017cal","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.bmc.2025.118348_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bmc.2025.118348_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.003","article-title":"Acute kidney injury associated with non-steroidal anti-inflammatory drugs","volume":"101","author":"Klomjit","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.bmc.2025.118348_bb0045","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.13005\/ojc\/390504","article-title":"Synthesis and cyclooxygenase-2 inhibitory activity evaluation of some pyridazine derivatives","volume":"39","author":"Imran","year":"2023","journal-title":"Orient J Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2025.118348_bb0055","doi-asserted-by":"crossref","first-page":"2000328","DOI":"10.1002\/ardp.202000328","article-title":"New indomethacin analogs as selective COX-2 inhibitors: synthesis, COX-1\/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies","volume":"354","author":"Abdellatif","year":"2021","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmc.2025.118348_bb0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1021\/acsmedchemlett.1c00004","article-title":"Synthesis, inhibitory activity, and in silico modeling of selective COX-1 inhibitors with a quinazoline core","volume":"12","author":"Dvorakova","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118348_bb0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/eve.13189","article-title":"Sparing the gut: COX \u22122 inhibitors herald a new era for treatment of horses with surgical colic","volume":"32","author":"Ziegler","year":"2019","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.bmc.2025.118348_bb0070","doi-asserted-by":"crossref","first-page":"107403","DOI":"10.1016\/j.bioorg.2024.107403","article-title":"Discovery of novel pyrazole based urea\/thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 inhibitors, with anti-cancer and anti-inflammatory activities","volume":"147","author":"Fadaly","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3389\/fphar.2020.00819","article-title":"Eicosanoids in cancer: prostaglandin E2 receptor 4 in cancer therapeutics and immunotherapy","volume":"11","author":"Ching","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2025.118348_bb0080","doi-asserted-by":"crossref","first-page":"107357","DOI":"10.1016\/j.bioorg.2024.107357","article-title":"Rapid identifying of COX-2 inhibitors from turmeric (Curcuma longa) by bioaffinity ultrafiltration coupled with UPLC-Q Exactive-orbitrap-MS and zebrafish-based in vivo validation","volume":"147","author":"Lan","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0085","first-page":"247","article-title":"Anti-inflammatory and side effects of cyclo-oxygenase inhibitors","volume":"59","author":"Suleyman","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bmc.2025.118348_bb0090","doi-asserted-by":"crossref","first-page":"115180","DOI":"10.1016\/j.ejmech.2023.115180","article-title":"4-(5-amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: design, synthesis, and biological assessments","volume":"250","author":"Ragab","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0095","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/ddr.22118","article-title":"Pyridazine derivatives as selective COX-2 inhibitors: a review on recent updates","volume":"84","author":"Ewieda","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2025.118348_bb0100","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2174\/1381612822666160224142812","article-title":"Polypharmacology in drug discovery: a review from systems pharmacology perspective","volume":"22","author":"Zhang","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2025.118348_bb0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1568010054022024","article-title":"Macrophages in inflammation","volume":"4","author":"Nagatoshi","year":"2005","journal-title":"Curr Drug Targets-Inflamm Allergy"},{"key":"10.1016\/j.bmc.2025.118348_bb0110","doi-asserted-by":"crossref","first-page":"105808","DOI":"10.1016\/j.bioorg.2022.105808","article-title":"Design and synthesis of novel 1,3,4-oxadiazole and 1,2,4-triazole derivatives as cyclooxygenase-2 inhibitors with anti-inflammatory and antioxidant activity in LPS-stimulated RAW264.7 macrophages","volume":"124","author":"Hamoud","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0014-5793(98)00299-3","article-title":"A novel lipopolysaccharide inducible C-C chemokine receptor related gene in murine macrophages","volume":"425","author":"Shimada","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2025.118348_bb0120","first-page":"1","article-title":"The pattern recognition receptors and lipopolysaccharides (LPS)-induced systemic inflammation","volume":"2","author":"Hung","year":"2017","journal-title":"Int J Res Stud Med Health Sci"},{"key":"10.1016\/j.bmc.2025.118348_bb0125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12906-017-1635-1","article-title":"Vaccaria hypaphorine alleviates lipopolysaccharide-induced inflammation via inactivation of NF\u03baB and ERK pathways in raw 264.7 cells","volume":"17","author":"Sun","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.bmc.2025.118348_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of nitric oxide in inflammatory diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bmc.2025.118348_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0005-2728(99)00029-8","article-title":"Nitric oxide and cell death","volume":"1411","author":"Murphy","year":"1999","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"10.1016\/j.bmc.2025.118348_bb0140","article-title":"The nuclear factor NF-kappaB pathway in inflammation., cold spring Harb","volume":"1","author":"Lawrence","year":"2009","journal-title":"Perspect Biol"},{"key":"10.1016\/j.bmc.2025.118348_bb0145","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","article-title":"P38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-\u03baB p65 transactivation mediated by tumor necrosis factor","volume":"273","author":"Vanden Berghe","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0150","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.fct.2010.02.014","article-title":"Artemisia fukudo essential oil attenuates LPS-induced inflammation by suppressing NF-\u03baB and MAPK activation in RAW 264.7 macrophages","volume":"48","author":"Yoon","year":"2010","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bmc.2025.118348_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/jm00187a013","article-title":"A new nonsteroidal analgesic-antiinflammatory agent. Synthesis and activity of 4-ethoxy-2-methyl-5-morpholino-3 (2H)-pyridazinone and related compounds","volume":"22","author":"Takaya","year":"1979","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0160","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1124\/jpet.104.070052","article-title":"ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor","volume":"311","author":"Harris","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2025.118348_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejmech.2019.03.036","article-title":"Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents","volume":"171","author":"Ahmed","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0170","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1016\/j.bmc.2008.04.007","article-title":"Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity","volume":"16","author":"Abouzid","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0223-5234(02)01336-3","article-title":"3-O-substituted benzyl pyridazinone derivatives as COX inhibitors","volume":"37","author":"Chintakunta","year":"2002","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0180","doi-asserted-by":"crossref","first-page":"103497","DOI":"10.1016\/j.bioorg.2019.103497","article-title":"New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation","volume":"95","author":"Ahmed","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0185","doi-asserted-by":"crossref","first-page":"107623","DOI":"10.1016\/j.bioorg.2024.107623","article-title":"Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives","volume":"150","author":"Ewieda","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0190","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1055\/s-0042-1759688","article-title":"Molecular docking, drug-likeness analysis, in silico pharmacokinetics, and toxicity studies of p-nitrophenyl hydrazones as anti-inflammatory compounds against COX-2, 5-LOX, and H+\/K+ ATPase","volume":"4","author":"Babalola","year":"2022","journal-title":"Pharm Front"},{"key":"10.1016\/j.bmc.2025.118348_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300773","article-title":"New anthranilic acid hydrazones as fenamate isosteres: synthesis, characterization, molecular docking, dynamics & in silico ADME, in vitro anti-inflammatory and anticancer activity studies","volume":"20","author":"\u015eenol","year":"2023","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmc.2025.118348_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30071472","article-title":"Pharmacological evaluation of novel hydrazide and hydrazone derivatives: anti-inflammatory and analgesic potential in preclinical models","volume":"30","author":"Zlatanova-Tenisheva","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118348_bb0205","first-page":"200","article-title":"Synthesis, computer aided screening and pharmacological evaluation of 2\/3-substituted-6(4-methyl phenyl)-4,5-dihydropyridazin-3(2H)-ones, and pyridazine substituted triazine","volume":"26","author":"Khokra","year":"2015","journal-title":"Indones J Pharm"},{"key":"10.1016\/j.bmc.2025.118348_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cber.19560890226","article-title":"\u00dcber die kondensation von l\u00e4vulins\u00e4ure mit aromatischen aldehyden","volume":"89","author":"Zaheer","year":"1956","journal-title":"Chem Ber"},{"key":"10.1016\/j.bmc.2025.118348_bb0215","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.bmc.2013.03.017","article-title":"Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity","volume":"21","author":"Lasheen","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/157340607781745393","article-title":"6-Aryl-4-oxohexanoic acids: synthesis, effects on eicosanoid biosynthesis,and anti-inflammatory in vivo-activities","volume":"3","author":"Abouzid","year":"2007","journal-title":"Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0225","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00044-009-9218-4","article-title":"Structure-based molecular design, synthesis, and in vivo anti-inflammatory activity of pyridazinone derivatives as nonclassic COX-2 inhibitors","volume":"19","author":"Abouzid","year":"2010","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2025.118348_bb0230","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1039\/P19720001091","article-title":"Pyridazines. Part IV. Action of Grignard reagents on 6-methyl- and 4,5-dihydro-6-\u03b1-styryl-pyridazin-3(2H)-ones","author":"Baddar","year":"1972","journal-title":"J Chem Soc, Perkin Trans 1"},{"key":"10.1016\/j.bmc.2025.118348_bb0235","doi-asserted-by":"crossref","first-page":"105325","DOI":"10.1016\/j.bioorg.2021.105325","article-title":"Design, synthesis, biological evaluation, and molecular docking studies of novel pyrazolo[3,4-d]pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers","volume":"116","author":"Sherbiny","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0240","doi-asserted-by":"crossref","first-page":"103007","DOI":"10.1016\/j.bioorg.2019.103007","article-title":"Recent advancement in the discovery and development of COX-2 inhibitors: insight into biological activities and SAR studies (2008\u20132019)","volume":"89","author":"Sharma","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0245","doi-asserted-by":"crossref","first-page":"110343","DOI":"10.1016\/j.pnpbp.2021.110343","article-title":"Translational evidence for the inflammatory response system (IRS)\/compensatory immune response system (CIRS) and neuroprogression theory of major depression","volume":"111","author":"Debnath","year":"2021","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bmc.2025.118348_bb0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/joca.1999.0292","article-title":"Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis","volume":"8","author":"Westacott","year":"2000","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.bmc.2025.118348_bb0255","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1038\/sj.onc.1207559","article-title":"Regulation of the apoptosis\u2013necrosis switch","volume":"23","author":"Nicotera","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2025.118348_bb0260","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jlb.65.6.792","article-title":"Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages","volume":"65","author":"Perkins","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bmc.2025.118348_bb0265","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bmc.2025.118348_bb0270","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S275595","article-title":"Reactive oxygen species: drivers of physiological and pathological processes","volume":"13","author":"Checa","year":"2020","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.bmc.2025.118348_bb0275","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00011-013-0639-7","article-title":"Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK\/STATs activation and ROS production","volume":"62","author":"Qi","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bmc.2025.118348_bb0280","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118348_bb0285","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118348_bb0290","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2025.118348_bb0295","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2025.118348_bb0305","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J Med Chem"},{"issue":"2012","key":"10.1016\/j.bmc.2025.118348_bb0310","first-page":"429320","article-title":"Anti-inflammatory activities of cinnamomum cassia constituents in-vitro and in-vivo","author":"Liao","year":"2012","journal-title":"Evid-Based Complement Altern Med"},{"key":"10.1016\/j.bmc.2025.118348_bb0315","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.3390\/molecules25184089","article-title":"Anti-inflammatory activity and ROS regulation effect of sinapaldehyde in LPS-stimulated RAW 264.7 macrophages","volume":"25","author":"Baek","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118348_bb0320","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1080\/14756366.2021.1956912","article-title":"Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and anticancer activities","volume":"36","author":"Sakr","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2025.118348_bb0325","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.bmc.2025.118348_bb0330","series-title":"Handbook of histopathological and histochemical techniques: including museum techniques","first-page":"671","author":"Culling","year":"2013"},{"key":"10.1016\/j.bmc.2025.118348_bb0335","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4049\/jimmunol.168.3.1441","article-title":"In vivo imaging of NF-\u03baB activity","volume":"168","author":"Carlsen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2025.118348_bb0340","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/S0002-9440(10)63588-2","article-title":"Regulatory effects of iNOS on acute lung inflammatory responses in mice","volume":"163","author":"Speyer","year":"2003","journal-title":"Am J Pathol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:55:34Z","timestamp":1758588934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625002895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":68,"alternative-id":["S0968089625002895"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118348","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of new pyridazinone derivatives as selective COX-2 inhibitors: In-vitro and in-vivo evaluation of the anti-inflammatory activity, histopathological studies and molecular modelling","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118348"}}